Locations
Vancouver, WA, USA · North America · Seattle, WA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Other
founded in
2011
Absci is a generative AI drug creation company focused on creating better biologics for patients faster. By leveraging deep learning AI and synthetic biology, Absci has developed an Integrated Drug Creation Platform that enables the design and validation of novel biologics, significantly reducing the time and cost associated with traditional drug discovery methods. The company partners with leaders in pharma, tech, and academia to tackle challenging targets, aiming to deliver life-changing medicines efficiently. With over 20 active programs and state-of-the-art facilities in multiple locations, Absci is positioned to revolutionize the biologics landscape and improve patient outcomes.
Something looks off?On-site & Remote